African Journal of
Pharmacy and Pharmacology

  • Abbreviation: Afr. J. Pharm. Pharmacol.
  • Language: English
  • ISSN: 1996-0816
  • DOI: 10.5897/AJPP
  • Start Year: 2007
  • Published Articles: 2286

Full Length Research Paper

E-Cadherin, beta-catenin and HER2 expression in prostate cancer tissues with perineural invasion and their correlation with Gleason score: A preliminary study

Sandra Regina Bonfim Rodrigues
  • Sandra Regina Bonfim Rodrigues
  • Disciplina de Onco - Hematologia da Faculdade de Medicina do ABC, Santo André, SP, Brazil.
  • Search for this author on:
  • Google Scholar
Maylla Yabiko
  • Maylla Yabiko
  • Disciplina de Onco - Hematologia da Faculdade de Medicina do ABC, Santo André, SP, Brazil.
  • Search for this author on:
  • Google Scholar
Rafael Bazan Thomaz
  • Rafael Bazan Thomaz
  • Disciplina de Onco - Hematologia da Faculdade de Medicina do ABC, Santo André, SP, Brazil.
  • Search for this author on:
  • Google Scholar
Therese Theodoro
  • Therese Theodoro
  • Disciplina de Onco - Hematologia da Faculdade de Medicina do ABC, Santo André, SP, Brazil.
  • Search for this author on:
  • Google Scholar
Beatriz Alves
  • Beatriz Alves
  • Disciplina de Onco - Hematologia da Faculdade de Medicina do ABC, Santo André, SP, Brazil.
  • Search for this author on:
  • Google Scholar
Ligia Ajaime Azzalis
  • Ligia Ajaime Azzalis
  • Instituto de Ciências Ambientais, Químicas e Farmacêuticas- UNIFESP - Campus Diadema, Diadema, SP, Brazil.
  • Search for this author on:
  • Google Scholar
Edimar Cristiano Pereira
  • Edimar Cristiano Pereira
  • Instituto de Ciências Ambientais, Químicas e Farmacêuticas- UNIFESP - Campus Diadema, Diadema, SP, Brazil.
  • Search for this author on:
  • Google Scholar
Virginia Berlanga Campos Junqueira
  • Virginia Berlanga Campos Junqueira
  • Instituto de Ciências Ambientais, Químicas e Farmacêuticas- UNIFESP - Campus Diadema, Diadema, SP, Brazil.
  • Search for this author on:
  • Google Scholar
Roseli Corazzini
  • Roseli Corazzini
  • Disciplina de Onco - Hematologia da Faculdade de Medicina do ABC, Santo André, SP, Brazil.
  • Search for this author on:
  • Google Scholar
Fernando Adami
  • Fernando Adami
  • Disciplina de Onco - Hematologia da Faculdade de Medicina do ABC, Santo André, SP, Brazil.
  • Search for this author on:
  • Google Scholar
Fernando Luiz Affonso Fonseca*
  • Fernando Luiz Affonso Fonseca*
  • 1. Disciplina de Onco - Hematologia da Faculdade de Medicina do ABC, Santo André, SP, Brazil. 2. Instituto de Ciências Ambientais, Químicas e Farmacêuticas- UNIFESP - Campus Diadema, Diadema, SP, Brazil.
  • Search for this author on:
  • Google Scholar


  •  Accepted: 11 February 2014
  •  Published: 15 February 2014

References

Bjartell A, Montironi R, Berney DM, Egevad L (2011). Tumor markers in prostate cancer II: diagnostic and prognostic cellular biomarkers. Acta Oncol. 50:76-84.
Crossref
 
Buhmeida A, Pyrhonen S, Laato M, Collan Y (2006). Prognostic factors in prostate cancer. Diagn. Pathol. 1:4-19.
Crossref
 
Delgado PO, Alves BCA, Gehrke FS, Kuniyoshi RK, Wroclavski ML, Del Gilglio A, Fonseca FLA (2013). Characterization of cell-free circulating DNA in plasma in patients with prostate cancer. Tumor Biol. 34:983–986.
Crossref
 
Grabowska MM, Sandhu B, Day ML (2012). EGF promotes de shedding of soluble E-cadherin in an ADAM 10-dependent manner in prostate epithelial cells. Cell Sign. 24:532-538.
Crossref
 
Kowalski PJ, Rubin MA, Kleer CG (2003). E-cadherin expression in primary carcinomas of the breast and its distant metastases. Breast Cancer Res. 5(6):R217-R221.
Crossref
 
Kril D, Thomas A, Wu S-P, Dhir R, Becich MJ (2001). E-cadherin expression and PSA secretion in human prostate epithelial cells. Urol. Res. 29:287-292.
Crossref
 
Kristiansen G (2012). Diagnostic and prognostic molecular biomarkers for prostate cancer. Histopathology 60:125-141.
Crossref 
 
Loric S, Paradism V, Gala J.-L, Berteau P, Bedossa P, Benoit G, Eschweger P (2001). Abnormal E-cadherin expression and prostate cell blood dissemination as markers of biological recurrence in cancer. Eur. J. Cancer 37:1475-1481.
Crossref
 
Masieri L, Minervini A, Vittori G, Lanciotti M, Lanzi F, Lapini A, Carini M, Serni S (2012). The role of free total PSA ratio in prediction of extracapsular tumor extension and biochemical recurrence after radical prostatectomy in patients with PSA between 4 and 10 mg/ml. Int. Urol. Nephrol. Epub Feb 8.
 
Matos LL, Stabenow E, Tavares MR, Ferraz AR, Capelozzi VL, Pinhal MAS (2006). Immunohistochemistry quantification by a digital computer-assisted method compared to semi-quantitative analysis. Clinics 61(5):417-424.
Crossref
 
Nagao K, Yamamoto Y, Hara T, Komatsu H, Inoue R, Matsuda K, Matsumoto H, Hara T, Sakano S, Baba Y, Matsuyama H (2011). Ki67 and BUBR1 may discriminate clinically insignificant prostate cancer in the PSA range < 4 ng/ml. Jpn. J. Clin. Oncol. 41(4):555-564.
Crossref
 
Serpa Neto A, Tobias-Machado M, Wroclawski ML, Fonseca FLA, Teixeira GK, Dal Moro AR et al (2010). HER-2/neu expression in prostate adenocarcinoma: a systematic review and meta-analysis. J. Urol. 184:842-850.
Crossref
 
Slater MD, Lauer C, Gidley-Baird A, Barden JA (2003). Markers for the development of early prostate cancer. J. Pathol. 199:368-372.
Crossref
 
Solit DB, Rosen N (2007). Targeting HER2 in Prostate Cancer: Where to Next? J. Clin. Oncol. 25(3):241-243.
Crossref
 
Veveris-Lowe TL, Lawrence MG, Collard RL, Bui L, Herington AC, Nicol DL, Clements JA (2005). Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells. Endocr. Relat. Cancer 12:631-643.
Crossref

 

Copyright © 2024 Author(s) retain the copyright of this article.

This article is published under the terms of the Creative Commons Attribution License 4.0

Back to Vol. 8 No. 6
Back to articles
SUBSCRIBE TO RSS
SUBMIT MANUSCRIPT
CONFERENCES